Holen Sie sich die Stockscreener-App
7.21
6.49%
-0.50
Handel nachbörslich:
7.20
-0.010
-0.14%
Schlusskurs vom Vortag:
$7.71
Offen:
$7.59
24-Stunden-Volumen:
34,292
Relative Volume:
3.96
Marktkapitalisierung:
$9.09M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-29.80M
KGV:
-6.0588
EPS:
-1.19
Netto-Cashflow:
$-25.19M
1W Leistung:
-9.31%
1M Leistung:
-5.87%
6M Leistung:
-34.00%
1J Leistung:
-46.11%
1-Tages-Spanne:
$7.11
$8.00
1-Wochen-Bereich:
$7.11
$8.4179
52-Wochen-Spanne:
$5.00
$17.40
Sensei Biotherapeutics Inc Stock (SNSE) Company Profile
Firmenname
Sensei Biotherapeutics Inc
Sektor
Branche
Telefon
(240) 243-8000
Adresse
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE
Vergleichen Sie SNSE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SNSE
Sensei Biotherapeutics Inc
|
7.21 | 10.02M | 0 | -29.80M | -25.19M | -1.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Sensei Biotherapeutics Inc Stock (SNSE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-05-14 | Eingeleitet | Stephens | Overweight |
| 2021-07-01 | Herabstufung | Berenberg | Buy → Hold |
| 2021-06-29 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2021-03-01 | Eingeleitet | Berenberg | Buy |
| 2021-03-01 | Eingeleitet | Citigroup | Buy |
| 2021-03-01 | Eingeleitet | Oppenheimer | Outperform |
| 2021-03-01 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Sensei Biotherapeutics Inc Aktie (SNSE) Neueste Nachrichten
What drives Sensei Biotherapeutics Inc. stock priceDynamic investment opportunities - jammulinksnews.com
Sensei Biotherapeutics Inc. Stock Analysis and ForecastDynamic capital growth - Autocar Professional
What analysts say about Sensei Biotherapeutics Inc. stockHigh-velocity gains - jammulinksnews.com
Is Sensei Biotherapeutics Inc. a good long term investmentFree Stock Chart Pattern Guide - jammulinksnews.com
What institutions are buying Sensei Biotherapeutics Inc. stock nowFree Stock Investment Growth Plan - beatles.ru
Is Sensei Biotherapeutics Inc. stock overhyped or has real potentialSecure Growth Trading Plan - Newser
Sensei Biotherapeutics (NASDAQ:SNSE) Stock Price Down 2.2% – Should You Sell? - Defense World
Why Sensei Biotherapeutics Inc. stock attracts strong analyst attentionFree Access to Investment Community - Newser
How Sensei Biotherapeutics Inc. stock performs during market volatilityFree Stock Market Real-Time Monitoring - Newser
What makes Sensei Biotherapeutics Inc. stock price move sharplyEarly Breakout Tracker - Newser
Sensei Biotherapeutics (SNSE) Trading Halted Amid Pending News | SNSE Stock News - GuruFocus
Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split | - GuruFocus
Sensei Biotherapeutics to implement 1-for-20 reverse stock split - Investing.com Australia
Sensei Biotherapeutics to implement 1-for-20 reverse stock split By Investing.com - Investing.com Canada
Sensei Biotherapeutics announces reverse stock split By Investing.com - Investing.com Canada
Sensei Biotherapeutics to Implement 1-for-20 Reverse Stock Split - MarketScreener
Sensei Biotherapeutics Announces Reverse Stock Split - TipRanks
Sensei Biotherapeutics Sets 1-for-20 Reverse Stock Split - Nasdaq
Sensei Biotherapeutics announces reverse stock split - Investing.com
Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split | SNSE Stock News - GuruFocus
Sensei Biotherapeutics (SNSE) Announces 1-for-20 Reverse Stock Split | SNSE Stock News - GuruFocus
Sensei Biotherapeutics Announces 1-For-20 Reverse Stock Split - marketscreener.com
Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split - GlobeNewswire
Sensei Bio's 1:20 Reverse Split Slashes Outstanding Shares from 25M to 1.3MWhat Investors Must Know - Stock Titan
What is HC Wainwright’s Forecast for SNSE Q2 Earnings? - Defense World
Sensei Biotherapeutics (NASDAQ:SNSE) Upgraded at HC Wainwright - Defense World
Sensei Biotherapeutics (SNSE) Receives a 'Buy' Rating from HC Wainwright | SNSE Stock News - GuruFocus
Sensei Biotherapeutics (SNSE) Receives Buy Rating from H.C. Wain - GuruFocus
Sensei Biotherapeutics (SNSE) Receives Buy Rating from H.C. Wainwright | SNSE Stock News - GuruFocus
H.C. Wainwright assumes Buy rating on Sensei Biotherapeutics stock By Investing.com - Investing.com Canada
VISTA Inhibitor Clinical Trials Market Insights and Drug Development Opportunities Report 2025-2028 Featuring Aurigene, Curis, Hummingbird Bioscience, Kineta, PharmAbcine, Sensei BiotherapeuticsResearchAndMarkets.com - FinancialContent
Sensei Biotherapeutics stockholders approve key proposals By Investing.com - Investing.com Nigeria
Sensei Biotherapeutics stockholders approve key proposals - Investing.com
Finanzdaten der Sensei Biotherapeutics Inc-Aktie (SNSE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):